Angiotargeting (IPE FP6)
Development of new therapies for brain tumours using encapsuled cell technology. Akronym: Cell Therapy “Angiotargeting”.
.
Coordinator: professor Rolf Bjerkvig
Contract duration: 2003-2008
Objectives:
- Development of an encapsulated cell therapy prototype that produces cancer growth inhibiting substances.
- Targeted therapeutic delivery using the encapsuled cell technology.
Homepage: angiotargeting
Last updated 4.12.2010